0001062993-23-011845.txt : 20230519
0001062993-23-011845.hdr.sgml : 20230519
20230519165643
ACCESSION NUMBER: 0001062993-23-011845
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230517
FILED AS OF DATE: 20230519
DATE AS OF CHANGE: 20230519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ashton William
CENTRAL INDEX KEY: 0001474553
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 23941188
MAIL ADDRESS:
STREET 1: C/O HARRISON CONSULTING GROUP
STREET 2: PO BOX 283
CITY: NEWTOWN SQUARE
STATE: PA
ZIP: 19073
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Societal CDMO, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 E. UWCHLAN AVE, SUITE 112
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 770-534-8239
MAIL ADDRESS:
STREET 1: 1 E. UWCHLAN AVE, SUITE 112
CITY: EXTON
STATE: PA
ZIP: 19341
FORMER COMPANY:
FORMER CONFORMED NAME: Recro Pharma, Inc.
DATE OF NAME CHANGE: 20131010
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0407
4
2023-05-17
0001588972
Societal CDMO, Inc.
SCTL
0001474553
Ashton William
C/O SOCIETAL CDMO, INC.
1 E UWCHLAN AVE, SUITE 112
EXTON
PA
19341
1
0
0
0
0
Common Stock
2023-05-17
4
A
0
73620
A
241400
D
Stock Option (right to buy)
0.74
2023-05-17
4
A
0
27229
0
A
2033-05-17
Common Stock
27229
27229
D
These restricted stock units will vest in full on May 17, 2024, subject to continued service with the Company. Restricted stock units convert into common stock on a one-for-one basis.
The stock option will vest in full on May 17, 2024, subject to continued service with the Company.
/s/ Ryan D. Lake, Attorney-in-Fact
2023-05-19